GGrantIndex
← Leaderboards

Jeffrey S Stringer

University Of Alabama At Birmingham

$39,511,365
Attributed
$46,742,186
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $11.8M · FY200525
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$46,742,186 · 14

By mechanism

U01$24,419,762 · 3
UM1$14,591,039 · 2
P30$3,611,978 · 4
R01$3,146,642 · 2
K23$626,265 · 2
R21$346,500 · 1

Top collaborators

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Zambia

Research focus

ZambiaSiteLaboratoriesEpidemicServicesLeadershipAids/Hiv ProblemCollaborationsCountryUniversitiesTrainingSuccessAffectScientistAfricaFundingBaseDeveloping CountriesAntiretroviral TherapyInvestmentsResourcesAfrica South Of The SaharaProgramsResearch Infrastructure

Grant awards (43)

Assessment of Twin Gestation with AI-Assisted Ultrasound$541,204
R01 · FY2025 · HD · contact PI
Global Health Core$178,564
P30 · FY2025 · AI · contact PI
UNC Center for AIDS Research Core I International$176,516
P30 · FY2024 · AI · contact PI
UNC Center for AIDS Research Core I International$212,630
P30 · FY2023 · AI · contact PI
UNC Center for AIDS Research Core I International$205,394
P30 · FY2022 · AI · contact PI
UNC Center for AIDS Research Core I International$360,496
P30 · FY2021 · AI · contact PI
A Randomized Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy$522,897
R01 · FY2020 · HD · contact PI
UNC Center for AIDS Research Core I International$181,375
P30 · FY2020 · AI · contact PI
A Randomized Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy$522,881
R01 · FY2019 · HD · contact PI
UNC Center for AIDS Research Core I International$313,223
P30 · FY2019 · AI · contact PI
Point-of-care virologic testing to improve outcomes of HIV-infected children$594,626
U01 · FY2018 · AI · contact PI
A Randomized Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy$522,882
R01 · FY2018 · HD · contact PI
UNC Center for AIDS Research Core I International$181,954
P30 · FY2018 · AI · contact PI
Point-of-care virologic testing to improve outcomes of HIV-infected children$791,374
U01 · FY2017 · AI · contact PI
A Randomized Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy$522,900
R01 · FY2017 · HD · contact PI
UNC Center for AIDS Research Core I International$178,804
P30 · FY2017 · AI · contact PI
A Pilot Study of Vaginal Progesterone to Reduce Preterm Birth among Women with HIV Receiving Antiretroviral Therapy in Pregnancy$157,500
R21 · FY2017 · HD · contact PI
A Randomized Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy$513,878
R01 · FY2016 · HD · contact PI
A Pilot Study of Vaginal Progesterone to Reduce Preterm Birth among Women with HIV Receiving Antiretroviral Therapy in Pregnancy$189,000
R21 · FY2016 · HD · contact PI
UNC Center for AIDS Research Core I International$178,516
P30 · FY2016 · AI · contact PI
University of North Carolina Global HIV Prevention and Treatment Clinical Trials$10,846,231
UM1 · FY2014 · AI
Point-of-care virologic testing to improve outcomes of HIV-infected children$960,564
U01 · FY2014 · AI · contact PI
Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit$2,176,000
UM1 · FY2013 · AI · contact PI
Point-of-care virologic testing to improve outcomes of HIV-infected children$910,446
U01 · FY2013 · AI · contact PI
Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit$1,568,808
UM1 · FY2012 · AI · contact PI
Point-of-care virologic testing to improve outcomes of HIV-infected children$964,981
U01 · FY2012 · AI · contact PI
Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit$725,895
U01 · FY2011 · AI · contact PI
International$544,427
P30 · FY2011 · AI · contact PI
Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit$3,171,214
U01 · FY2010 · AI · contact PI
International$523,803
P30 · FY2010 · AI · contact PI
Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit$2,786,202
U01 · FY2009 · AI · contact PI
International$303,363
P30 · FY2009 · AI · contact PI
Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit$4,594,591
U01 · FY2008 · AI · contact PI
International Research$72,913
P30 · FY2008 · AI · contact PI
Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit$2,102,248
U01 · FY2007 · AI · contact PI
UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT$577,198
U01 · FY2006 · AI · contact PI
UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT$3,253,539
U01 · FY2005 · AI
CAREER DEVELOPMENT AWARD IN PERINATAL HIV PREVENTION$125,253
K23 · FY2005 · AI
UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT$2,986,884
U01 · FY2004 · AI
CAREER DEVELOPMENT AWARD IN PERINATAL HIV PREVENTION$125,253
K23 · FY2004 · AI
CAREER DEVELOPMENT AWARD IN PERINATAL HIV PREVENTION$125,253
K23 · FY2003 · AI
CAREER DEVELOPMENT AWARD IN PERINATAL HIV PREVENTION$125,253
K23 · FY2002 · AI
CAREER DEVELOPMENT AWARD IN PERINATAL HIV PREVENTION$125,253
K23 · FY2001 · HD